U.S. Food and Drug Administration

melanie wasser unsplash

United States FDA approves form of ketamine for depression treatment

Esketamine is the first new drug treatment approved for depression in decades. Current drugs target the feel-good brain chemical serotonin, and can take weeks or months to kick in. Ketamine targets a chemical called glutamate that is thought to restore brain connections that help relieve depression.